BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32641375)

  • 21. Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patients.
    Yoon JE; Sunwoo JS; Kim JS; Roh H; Ahn MY; Woo HY; Lee KB
    J Diabetes Complications; 2017 Feb; 31(2):390-394. PubMed ID: 27956053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microvascular disease and cardiovascular outcomes among individuals with type 2 diabetes.
    Kaze AD; Santhanam P; Erqou S; Bertoni AG; Ahima RS; Echouffo-Tcheugui JB
    Diabetes Res Clin Pract; 2021 Jun; 176():108859. PubMed ID: 33989668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BMI, Weight Change, and Dementia Risk in Patients With New-Onset Type 2 Diabetes: A Nationwide Cohort Study.
    Nam GE; Park YG; Han K; Kim MK; Koh ES; Kim ES; Lee MK; Kim B; Hong OK; Kwon HS
    Diabetes Care; 2019 Jul; 42(7):1217-1224. PubMed ID: 31177182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of early mortality and cardiovascular disease according to the presence of recently diagnosed diabetes and requirement for insulin treatment: A nationwide study.
    Lee YB; Han K; Kim B; Choi MS; Park J; Kim M; Jin SM; Hur KY; Kim G; Kim JH
    J Diabetes Investig; 2021 Oct; 12(10):1855-1863. PubMed ID: 33662172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary.
    Kiss Z; Rokszin G; Abonyi-Tóth Z; Jermendy G; Kempler P; Aradi D; Wittmann I
    Cardiovasc Diabetol; 2018 Jul; 17(1):107. PubMed ID: 30053870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial stiffness as a risk factor for cardiovascular events and all-cause mortality in people with Type 2 diabetes.
    Sharif S; Visseren FLJ; Spiering W; de Jong PA; Bots ML; Westerink J;
    Diabet Med; 2019 Sep; 36(9):1125-1132. PubMed ID: 30920676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes: A Nationwide Cohort Study.
    Modin D; Claggett B; Køber L; Schou M; Jensen JUS; Solomon SD; Vardeny O; Knop FK; Nielsen SD; Fralick M; Torp-Pedersen C; Gislason G; Biering-Sørensen T
    Diabetes Care; 2020 Sep; 43(9):2226-2233. PubMed ID: 32647052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes.
    Fuller JH; Stevens LK; Wang SL
    Diabetologia; 2001 Sep; 44 Suppl 2():S54-64. PubMed ID: 11587051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GF
    Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early mortality and cardiovascular disease, varied association with body mass index and its changes in insulin-treated diabetes: a nationwide study.
    Lee YB; Kim B; Park J; Kim M; Choi MS; Kim G; Jin SM; Hur KY; Han K; Kim JH
    Int J Obes (Lond); 2021 Nov; 45(11):2482-2489. PubMed ID: 34344992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
    Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
    JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Nunez L; Gudbjörnsdóttir S; Eliasson B
    Diabetologia; 2009 Jan; 52(1):65-73. PubMed ID: 18985314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study.
    Lee HJ; Choi EK; Han KD; Kim DH; Lee E; Lee SR; Oh S; Lip GYH
    Cardiovasc Diabetol; 2020 Jun; 19(1):78. PubMed ID: 32534567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II.
    Drinkwater JJ; Davis TME; Hellbusch V; Turner AW; Bruce DG; Davis WA
    Cardiovasc Diabetol; 2020 Mar; 19(1):43. PubMed ID: 32234054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity Paradox.
    Edqvist J; Rawshani A; Adiels M; Björck L; Lind M; Svensson AM; Gudbjörnsdottir S; Sattar N; Rosengren A
    Diabetes Care; 2019 Jul; 42(7):1297-1304. PubMed ID: 31048408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study.
    Jil M; Rajnikant M; Richard D; Iskandar I
    Diab Vasc Dis Res; 2017 Jul; 14(4):295-303. PubMed ID: 28330386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between serum 25(OH)D
    Samefors M; Scragg R; Länne T; Nyström FH; Östgren CJ
    Diabet Med; 2017 Mar; 34(3):372-379. PubMed ID: 27862247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Body mass index in early and middle adult life: prospective associations with myocardial infarction, stroke and diabetes over a 30-year period: the British Regional Heart Study.
    Owen CG; Kapetanakis VV; Rudnicka AR; Wathern AK; Lennon L; Papacosta O; Cook DG; Wannamethee SG; Whincup PH
    BMJ Open; 2015 Sep; 5(9):e008105. PubMed ID: 26373398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study.
    Lee JH; Han K; Huh JH
    Cardiovasc Diabetol; 2020 Apr; 19(1):44. PubMed ID: 32238157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of hematological parameters for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
    Cardoso CRL; Leite NC; Salles GF
    Cardiovasc Diabetol; 2021 Jul; 20(1):133. PubMed ID: 34229668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.